SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Jun-23 4:02 PM View: | Black Diamond Therapeutics,... (BDTX) | 27-Jun-23 | Private Sale (Planned) | 25,000 | $6.70 | $167,500.00 | (3%) 961.57K to 936.57K | |
06-Jan-21 6:21 PM View: | Black Diamond Therapeutics,... (BDTX) | 04-Jan-21 | Option Exercise | 3,000 | $6.42 | $19,260.00 | < 1% 970.57K to 973.57K | |
06-Jan-21 6:21 PM View: | Black Diamond Therapeutics,... (BDTX) | 04-Jan-21 | Market Option Sale (Planned) | 3,000 | $31.13 | $93,376.20 | (< 1%) 973.57K to 970.57K | 14% |
06-Jan-21 6:21 PM View: | Black Diamond Therapeutics,... (BDTX) | 04-Jan-21 | Market Sale (Planned) | 9,000 | $31.13 | $280,129.00 | (< 1%) 970.57K to 961.57K | 14% |
16-Dec-20 7:39 PM View: | Black Diamond Therapeutics,... (BDTX) | 15-Dec-20 | Option Exercise | 2,500 | $6.42 | $16,050.00 | < 1% 968.07K to 970.57K | |
03-Dec-20 4:17 PM View: | Black Diamond Therapeutics,... (BDTX) | 01-Dec-20 | Option Exercise | 3,000 | $6.42 | $19,260.00 | < 1% 977.07K to 980.07K | |
03-Dec-20 4:17 PM View: | Black Diamond Therapeutics,... (BDTX) | 01-Dec-20 | Planned Option Sale | 3,000 | $32.71 | $98,143.40 | (< 1%) 980.07K to 977.07K | |
03-Dec-20 4:17 PM View: | Black Diamond Therapeutics,... (BDTX) | 01-Dec-20 | Sale (Planned) | 9,000 | $32.71 | $294,430.00 | (< 1%) 977.07K to 968.07K | |
03-Nov-20 7:56 PM View: | Black Diamond Therapeutics,... (BDTX) | 02-Nov-20 | Option Exercise | 3,000 | $6.42 | $19,260.00 | < 1% 986.07K to 989.07K | |
03-Nov-20 7:56 PM View: | Black Diamond Therapeutics,... (BDTX) | 02-Nov-20 | Planned Option Sale | 3,000 | $31.14 | $93,414.10 | (< 1%) 989.07K to 986.07K | |
03-Nov-20 7:56 PM View: | Black Diamond Therapeutics,... (BDTX) | 02-Nov-20 | Sale (Planned) | 9,000 | $31.14 | $280,242.00 | (< 1%) 986.07K to 977.07K | |
02-Oct-20 5:07 PM View: | Black Diamond Therapeutics,... (BDTX) | 01-Oct-20 | Option Exercise | 3,000 | $6.42 | $19,260.00 | < 1% 995.07K to 998.07K | |
02-Oct-20 5:07 PM View: | Black Diamond Therapeutics,... (BDTX) | 01-Oct-20 | Planned Option Sale | 3,000 | $30.33 | $90,990.60 | (< 1%) 998.07K to 995.07K | |
02-Oct-20 5:07 PM View: | Black Diamond Therapeutics,... (BDTX) | 01-Oct-20 | Sale (Planned) | 9,000 | $30.33 | $272,972.00 | (< 1%) 995.07K to 986.07K | |
05-Feb-20 5:57 PM View: | Black Diamond Therapeutics,... (BDTX) | 03-Feb-20 | Conversion | 242,904 | -- | -- | 50% 482.67K to 725.57K | |
05-Feb-20 5:57 PM View: | Black Diamond Therapeutics,... (BDTX) | 03-Feb-20 | Conversion | 23,090 | -- | -- | 3% 725.57K to 748.66K | |
05-Feb-20 5:57 PM View: | Black Diamond Therapeutics,... (BDTX) | 03-Feb-20 | Conversion | 4,354 | -- | -- | < 1% 748.66K to 753.01K | |
16-Oct-14 9:54 PM View: | Metastat, Inc. (MTST) | 14-Oct-14 | Grant | 104,935 | -- | -- | 35% 300.68K to 405.62K | |
24-Jul-14 7:57 PM View: | Metastat, Inc. (MTST) | 22-Jul-14 | Grant | 12,500 | -- | -- | 12% 100.0K to 112.5K | |
16-Oct-14 9:54 PM View: | Metastat, Inc. (MTST) | 14-Jul-14 | Grant | 188,182 | $1.10 | $207,000.00 | 167% 112.5K to 300.68K | (93%) |
16-Oct-14 9:54 PM View: | Metastat, Inc. (MTST) | 30-Jun-14 | Grant | 39,091 | $1.10 | $43,000.10 | 13% 300.63K to 339.72K | |
09-Jun-10 5:30 PM View: | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 8 | $57.50 | $460.00 | (100%) 8 to 0 | < 1% |
07-Jun-10 7:44 PM View: | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 9,809 | $57.50 | $564,018.00 | (73%) 13.35K to 3.54K | < 1% |
07-Jun-10 7:44 PM View: | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 3,531 | $57.50 | $203,032.00 | (100%) 3.54K to 8 | < 1% |
04-May-10 9:51 AM View: | OSI Pharmaceuticals Inc. (OSIP) | 01-May-10 | Payment of Exercise | 906 | $58.67 | $53,155.00 | (6%) 14.25K to 13.34K | (< 1%) |